- Home
- KNSA vs TWST Comparison
KNSA vs TWST Comparison
Compare KNSA & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | TWST |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.2B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | KNSA | TWST |
|---|---|---|
| Price | $63.61 | $96.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $60.86 | $46.88 |
| AVG Volume (30 Days) | 996.3K | ★ 1.9M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | 63.89 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | $376,572,000.00 |
| Revenue This Year | $37.48 | $18.91 |
| Revenue Next Year | $17.87 | $15.07 |
| P/E Ratio | $232.74 | ★ N/A |
| Revenue Growth | ★ 60.09 | 20.32 |
| 52 Week Low | $26.27 | $23.30 |
| 52 Week High | $67.53 | $105.47 |
Technical Indicators
Market Signals| Indicator | KNSA | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 58.05 |
| Support Level | $37.62 | $87.57 |
| Resistance Level | $67.53 | $105.47 |
| Average True Range (ATR) | 2.72 | 6.81 |
| MACD | -0.39 | -1.42 |
| Stochastic Oscillator | 46.82 | 48.95 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.